66--HD-X02 Implants.
ID: 75N92024Q1098Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NHLBIBETHESDA, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of HD-X02 Implants. This presolicitation opportunity falls under the NAICS code 334516, which pertains to Analytical Laboratory Instrument Manufacturing, and is classified under the PSC code 6640 for Laboratory Equipment and Supplies. The HD-X02 Implants are critical for advancing research and development in the biomedical field, supporting various health initiatives. Interested vendors can reach out to Noelle Decenzo at noelle.decenzo@nih.gov or call 301-402-5571 for further details regarding this opportunity.

    Point(s) of Contact
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    66--HD-X02 Implants.
    Currently viewing
    Presolicitation
    Similar Opportunities
    Depuy Synthes Sales Inc. Screws and Plates
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure screws and plates from Depuy Synthes Sales Inc. for use in craniotomy surgeries at the NIH Clinical Center in Bethesda, Maryland. This acquisition aims to replenish essential components of the Fixation Sets currently utilized by the Department of Perioperative Medicine, ensuring that surgeons have the necessary tools for effective skull reconstruction post-surgery. The items requested are critical implants that remain in patients after surgery, and Depuy Synthes Sales Inc. is the exclusive manufacturer of these specific products, which have been in use for over five years. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 7, 2024, at 6:30 AM EST, as this procurement will follow simplified acquisition procedures under FAR Part 13.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking sources for the procurement of Illumina Reagents and Consumables. This opportunity aims to identify potential suppliers capable of providing essential reagents and consumables used in genomic sequencing and related research applications. These products are critical for advancing biomedical research and supporting various health initiatives. Interested vendors should reach out to Ethan Mueller at ethan.mueller@nih.gov for further details regarding this sources sought notice.
    A--NIH NeuroBioBank Brain and Tissue Repository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is soliciting proposals for the establishment of the NIH NeuroBioBank Brain and Tissue Repository under Request for Proposal (RFP) No. 75N95024R00124. The objective of this procurement is to create and manage contract collection sites for acquiring, storing, and distributing human brain and central nervous system tissues for research, aimed at advancing the understanding and treatment of nervous system disorders. This initiative is critical for enhancing biomedical research by improving access to well-characterized specimens, thereby supporting scientific investigations into neurological conditions. Proposals are due by November 14, 2024, with the anticipated contract performance period starting on May 1, 2025, and extending through optional years. Interested parties can direct inquiries to Robin D. Knightly at robin.knightly@nih.gov or call +1 301 827 5302 for further information.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.
    A--JHS Field Center
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the renewal of the Jackson Heart Study (JHS) Field Center. This opportunity involves research and development services in the health sector, focusing on the physical, engineering, and life sciences, as outlined under NAICS code 541715. The JHS is a significant initiative aimed at understanding cardiovascular health in African American populations, highlighting the importance of this research in public health. Interested parties can reach out to Matthew Jovinelli at matthew.jovinelli@nih.gov or (301) 827-8315 for further details regarding the solicitation process.
    Title: Global Life Sciences Sepax Cell Separation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed-price contract for the procurement of Global Life Sciences Sepax Cell Separation Kits and Ficoll Paque Premium reagents. The NIH's Department of Transfusion Medicine requires these items to support the manufacturing of cell-based therapies for patients with advanced metastatic cancer, utilizing the Sepax C-Pro Cell Processing Instruments. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source award to Cytiva-Global Life Sciences Solutions USA LLC, with capability statements due by November 3, 2024, at 12:00 PM EST. Interested parties can direct inquiries to Sheri Eiri at sheri.eiri@nih.gov.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Device Investment Development
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute on Drug Abuse (NIDA), intends to award a sole-source contract for consulting services related to medical device development under the Blueprint MedTech Initiative. The objective is to procure a subject matter expert with extensive experience in neurotechnology and mental health product development, who will provide strategic guidance and oversight for projects aimed at accelerating the translation of innovative medical devices for neurological disorders. This initiative, established in 2019 with a funding allocation of $32 million, seeks to facilitate the development of groundbreaking technologies and ensure their progression to clinical studies by 2027. Interested parties may submit their qualifications by November 8, 2024, to the designated contacts, Tracy Cain and Llakim Dubroff, at the NIH.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under solicitation number 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, and distribute a variety of drug compounds essential for drug abuse and addiction research, including controlled and uncontrolled substances, while ensuring compliance with DEA regulations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, aims to enhance research capabilities in the field of drug abuse, with proposals due by November 15, 2024, at 1:00 PM (Eastern Time). Interested parties should contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    Deep Tissue Imaging
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from institutions and companies with expertise in deep tissue optical imaging technologies. The objective is to gather insights on capabilities related to overcoming the limitations of light penetration in tissue, which affects the applications of optical imaging in biomedical and clinical research. This initiative is crucial for advancing technologies such as adaptive optics, wavefront shaping, and biophotonics, which can enhance imaging capabilities. Interested parties are encouraged to provide their organizational details and expertise, and may contact Jonathan Pollock at jpollock@mail.nih.gov or Robert Bailey at rob.bailey@nih.gov for further information.
    CYTEK AURORA 5 LASER WITH LOADER - UV/V/B/YG/R - PREMIUM SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a premium service agreement for a Cytek Aurora 5 laser with loader, which is essential for advanced laboratory applications. The procurement includes comprehensive maintenance services, such as preventive inspections, technical support, and on-site assistance, ensuring optimal functionality of the equipment throughout the contract period from December 1, 2024, to November 20, 2025. This acquisition is critical for supporting the NIH's research initiatives in allergy and infectious diseases, emphasizing the importance of reliable laboratory equipment and services. Interested vendors must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 13, 2024, at 12:00 am EST, and can contact Maliaka Pinkney or Jesse D Weidow for further inquiries.